Jonathan Lerner
Jonathan Lerner
Post-doctoral researcher, University of Pennsylvania
Dirección de correo verificada de
Citado por
Citado por
Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progression
M Candolfi, JF Curtin, WS Nichols, AKMG Muhammad, GD King, ...
Journal of neuro-oncology 85, 133-148, 2007
Release of HMGB1 in response to proapoptotic glioma killing strategies: efficacy and neurotoxicity
M Candolfi, K Yagiz, D Foulad, GE Alzadeh, M Tesarfreund, ...
Clinical Cancer Research 15 (13), 4401-4414, 2009
A changing paradigm of transcriptional memory propagation through mitosis
KC Palozola, J Lerner, KS Zaret
Nature reviews Molecular cell biology 20 (1), 55-64, 2019
Chromatin scanning by dynamic binding of pioneer factors
KS Zaret, J Lerner, M Iwafuchi-Doi
Molecular cell 62 (5), 665-667, 2016
Two-parameter mobility assessments discriminate diverse regulatory factor behaviors in chromatin
J Lerner, PA Gomez-Garcia, RL McCarthy, Z Liu, M Lakadamyali, ...
Molecular cell 79 (4), 677-688. e6, 2020
Human mutations affect the epigenetic/bookmarking function of HNF1B
J Lerner, A Bagattin, F Verdeguer, MP Makinistoglu, S Garbay, T Felix, ...
Nucleic acids research 44 (17), 8097-8111, 2016
A novel bicistronic high-capacity gutless adenovirus vector that drives constitutive expression of herpes simplex virus type 1 thymidine kinase and tet-inducible expression of …
M Puntel, A Muhammad, M Candolfi, A Salem, K Yagiz, C Farrokhi, ...
Journal of virology 84 (12), 6007-6017, 2010
Study of the efficacy, biodistribution, and safety profile of therapeutic gutless adenovirus vectors as a prelude to a phase I clinical trial for glioblastoma
AKMG Muhammad, M Puntel, M Candolfi, A Salem, K Yagiz, C Farrokhi, ...
Clinical Pharmacology & Therapeutics 88 (2), 204-213, 2010
Low-dose aspirin protective effects are correlated with deregulation of HNF factor expression in the preeclamptic placentas from mice and humans
A Ducat, A Vargas, L Doridot, A Bagattin, J Lerner, JL Vilotte, C Buffat, ...
Cell Death Discovery 5 (1), 94, 2019
Two-parameter single-molecule analysis for measurement of chromatin mobility
J Lerner, PA Gómez-García, RL McCarthy, Z Liu, M Lakadamyali, ...
STAR protocols 1 (3), 100223, 2020
Los procesos pedagógicos y sus vicisitudes. Reflexiones y aproximaciones. Texto inédito. Biblioteca Luis Echavarría Villegas
J Lerner, A Vargas
Universidad EAFIT, Medellín, 2004
Evaluation of proapototic transgenes to use in combination with Flt3L in an immune‐stimulatory gene therapy approach for Glioblastoma multiforme (GBM)
M Candolfi, GD King, AKMG Muhammad, M Puntel, KM Kroeger, C Liu, ...
The FASEB Journal 22, 1077.13-1077.13, 2008
A LAMP sequencing approach for high-throughput co-detection of SARS-CoV-2 and influenza virus in human saliva
R Warneford-Thomson, PP Shah, P Lundgren, J Lerner, J Morgan, ...
Elife 11, e69949, 2022
Growth of pancreatic cancers with hemizygous chromosomal 17p loss of MYBBP1A can be preferentially targeted by PARP inhibitors
A Hsieh, JR Pitarresi, J Lerner, G Donahue, D Hsiehchen, AK Rustgi, ...
Science Advances 6 (49), eabc4517, 2020
Deregulation Debate in the German Electricity Supply Industry
J Lerner, C Riechmann
Utilities Law Review 9, 33-41, 1998
Distinct Chromatin Scanning Modes Lead to Targeting of Compacted Chromatin by Pioneer Factors FOXA1 and SOX2
J Lerner, A Katznelson, J Zhang, KS Zaret
bioRxiv, 2022.12. 22.521655, 2022
Carm1 regulates the speed of C/EBPα-induced transdifferentiation by a cofactor stealing mechanism
GT Garcia, E Kowenz-Leutz, TV Tian, A Klonizakis, J Lerner, ...
bioRxiv, 2022.10. 03.510647, 2022
COV-ID: A LAMP sequencing approach for high-throughput co-detection of SARS-CoV-2 and influenza virus in human saliva
R Warneford-Thomson, PP Shah, P Lundgren, J Lerner, BS Abella, ...
medRxiv, 2021.04. 23.21255523, 2021
43. Enhancement of Oncolytic Properties of Genetically-Engineered Fusogenic Newcastle Disease Virus through Antagonism of Cellular Innate Immune Responses
M Candolfi, W Xiong, AG Muhammad, M Puntel, C Liu, KM Kroeger, ...
Molecular Therapy 16, 1, 2008
Validation of HSV1-TK plus ganciclovir in combination with the immune-stimulant Flt3L as a powerful therapeutic target for Glioblastoma multiforme in a preclinical syngeneic …
M CANDOLFI, G King, A Muhammad, M Puntel, K Kroeger, C Liu, ...
Cancer Research 68 (9_Supplement), 2870-2870, 2008
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20